Victrex Gestion
Gestion contrôle des critères 1/4
Le PDG Victrex est James Routh, nommé en Jan2026, a un mandat de moins d'un an. détient directement 0.042% des actions de la société, d'une valeur de £ 351.34K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 0.3 ans et 3.5 ans.
Informations clés
James Routh
Directeur général
n/a
Rémunération totale
| Pourcentage du salaire du PDG | n/a |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 0.04% |
| Durée moyenne d'occupation des postes de direction | less than a year |
| Durée moyenne du mandat des membres du conseil d'administration | 3.5yrs |
Mises à jour récentes de la gestion
Recent updates
Mise à jour du récit • Sep 09
VCT: Profit Improvement Plan And Leadership Transition Will Shape Future Re Rating
Analysts have raised their price target on Victrex from £8.49 to £9.70, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations. What’s in the News for Victrex Victrex appointed Chris Gilbert as Interim Chief Financial Officer, effective 1 September 2026, with experience at Elementis plc and Deloitte LLP, according to company disclosures.Mise à jour du récit • Jun 22
VCT: Margin Progress And Lower P/E Framework Will Support Future Re Rating
Analysts have nudged their Victrex price target slightly lower to £8.49 from £8.51, citing updated assumptions around revenue growth, profit margins and future P/E expectations that leave the overall valuation broadly unchanged. What's in the News No recent Victrex specific news items or key developments were available from the provided sources.
Mise à jour du récit • Jun 05
VCT: Updated Discount Rate And P E Assumptions Will Shape Future Rerating
Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E multiples that slightly reshape the company’s risk and return profile. What's in the News No recent company specific news for Victrex has been provided in the available sources.Mise à jour du récit • May 21
VCT: Margin Execution And Lower P/E Framework Will Support Future Re Rating
Analysts have trimmed their implied price target on Victrex by about £0.39, citing updated assumptions around profit margins, revenue growth and a lower future P/E multiple following recent Street research. Analyst Commentary Street research around Victrex has shifted to a more cautious stance on valuation, with the latest move being a £1.00 cut to the implied price target from JPMorgan.Mise à jour du récit • May 01
VCT: Cautious P E And Discount Rate Assumptions Will Shape Future Rerating
Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. These changes modestly adjust their outlook on the shares.Mise à jour du récit • Apr 17
VCT: Cautious Growth And Margin Assumptions Will Shape Future P E Rerating
Analysts have lowered their price target on Victrex by £1.00, citing updates to assumptions around discount rate, revenue growth, profit margin and future P/E that collectively suggest a more balanced risk and return profile. Analyst Commentary Recent commentary around Victrex has tilted more cautious, with the latest £1.00 cut in the price target, including the 100 GBp adjustment referenced in recent research, highlighting increased focus on valuation and execution risks.Mise à jour du récit • Apr 03
VCT: Refined Cash Flow Assumptions Will Support Future Re Rating Potential
Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around discount rates, revenue growth, and profit margins as key drivers of the revision. Analyst Commentary JPMorgan has reduced its price target on Victrex by £1.00, reflecting refreshed assumptions around discount rates, revenue growth, and margins.
Mise à jour du récit • Mar 19
VCT: Future Upside Will Be Anchored By Resilient Earnings Framework
Analysts have trimmed their price target on Victrex by £1.00, reflecting slightly lower fair value estimates and modestly softer assumptions for revenue growth and profit margins, while still using a similar discount rate and future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts view the £1.00 reduction in the price target as a fine tuning of fair value rather than a shift in the long term thesis, with the core assumptions on discount rate and future P/E multiple kept broadly intact.Mise à jour du récit • Mar 05
VCT: Future Upside Will Be Supported By Resilient Earnings Assumptions
Analysts have trimmed their price target for Victrex to £7.32 from £7.48. This reflects updated views on its long term fair value, discount rate, revenue growth, profit margin and future P/E assumptions.Mise à jour du récit • Feb 19
VCT: Higher Growth Assumptions Will Set Up Future Re Rating Opportunity
Analysts have trimmed their price target for Victrex to £8.90. This reflects slightly higher assumed discount and revenue growth rates, together with a small adjustment to forecast profit margins and future P/E expectations.Mise à jour du récit • Feb 05
VCT: Sector Downgrade And Lower Future P E Multiple Will Cap Rerating Potential
Analysts have trimmed their price expectations for Victrex, reflecting slightly higher discount rate assumptions, modestly different revenue growth and profit margin forecasts, and a lower future P/E multiple in light of more cautious sector views on European chemicals. Analyst Commentary Bearish analysts have taken a more cautious stance on Victrex, in line with a broader push to reduce risk within European chemicals.Article d’analyse • Jan 27
Does Victrex (LON:VCT) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Mise à jour du récit • Jan 22
VCT: Sector Downgrade Will Set Up Opportunity For Future Re‑Rating
Analysts have reduced their fair value estimate for Victrex from £11.00 to £8.90, citing more cautious views on diversified chemicals and a preference for other parts of the European chemicals sector as key drivers of the updated price target assumptions. Analyst Commentary Recent research highlights a more cautious stance on diversified chemicals, with Victrex now grouped alongside peers where sentiment is restrained compared with preferred sub sectors such as industrial gases, ingredients, and distributors.Article d’analyse • Jan 09
Victrex (LON:VCT) Has Affirmed Its Dividend Of £0.4614
The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend of £0.4614 per share on the 27th of...Mise à jour du récit • Jan 08
VCT: Future Upside Will Be Driven By Resilient Earnings Power
Narrative Update Analysts have trimmed their fair value estimate for Victrex to reflect a lower price target of £9.40 from £11.00, citing a more cautious stance on European chemicals while still noting relatively steady assumptions for growth, margins and future P/E. Analyst Commentary Recent research updates on Victrex point to a more mixed stance, with some analysts maintaining a constructive view on the shares and others taking a more cautious approach to the broader European chemicals space.Mise à jour du récit • Dec 24
VCT: Sector Caution And Rating Downgrade Will Pressure Share Rerating Potential
Analysts have trimmed their fair value estimate for Victrex from £6.75 to £5.75, reflecting a slightly higher discount rate, softer medium term revenue and margin expectations, and recent price target cuts from the Street. Analyst Commentary Recent Street updates underline a more cautious stance on Victrex, with bearish analysts revising ratings and price targets lower in response to sector headwinds and company specific execution risks.Article d’analyse • Dec 24
Victrex (LON:VCT) Is Due To Pay A Dividend Of £0.4614
The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend on the 27th of February, with investors...Mise à jour du récit • Dec 10
VCT: Future Upside Will Be Driven By Medical Volume Rebound
Analysts have trimmed their price targets on Victrex, cutting the implied fair value by roughly 2 percent to reflect softer margin expectations and sector headwinds, even as they acknowledge improving revenue growth prospects along with a higher future P/E multiple. Analyst Commentary Street commentary on Victrex has become more balanced, with recent notes highlighting both improving medium term growth prospects and persistent execution risks that could cap near term upside.Article d’analyse • Dec 10
We Like The Quality Of Victrex's (LON:VCT) Earnings
Shareholders appeared to be happy with Victrex plc's ( LON:VCT ) solid earnings report last week. This reaction by the...Article d’analyse • Dec 05
Victrex (LON:VCT) Has Announced A Dividend Of £0.4614
Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 27th of February. Based on this payment, the dividend...Mise à jour du récit • Nov 26
VCT: Future Recovery Will Be Driven By Medical Volume Rebound
Victrex's analyst price targets have been revised downward, with a notable reduction from previous estimates such as 1,100 GBp to 940 GBp. Analysts cite ongoing caution towards the European chemicals sector and softer expectations for the company's recovery. Analyst Commentary Recent analyst assessments reflect a shift in sentiment towards Victrex's near-term performance and sector positioning.Mise à jour du récit • Nov 11
VCT: Future Leadership Transition Will Guide Recovery As Margins Improve
Analysts have reduced their price targets for Victrex, with consensus moving from approximately £8.77 to £8.11 per share. This reflects concerns about weaker profit margins and slower growth forecasts in the chemicals sector.Article d’analyse • Oct 11
Market Participants Recognise Victrex plc's (LON:VCT) Earnings
When close to half the companies in the United Kingdom have price-to-earnings ratios (or "P/E's") below 16x, you may...Article d’analyse • Jun 28
Capital Allocation Trends At Victrex (LON:VCT) Aren't Ideal
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Article d’analyse • May 19
We Think Victrex's (LON:VCT) Healthy Earnings Might Be Conservative
The market seemed underwhelmed by the solid earnings posted by Victrex plc ( LON:VCT ) recently. We have done some...Article d’analyse • May 15
Victrex's (LON:VCT) Dividend Will Be £0.1342
Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.1342 per share on 27th of June. This makes the...Nouveau récit • May 12
China Plant And Magma Programme Will Expand Market Reach
Initiatives like Project Vista and the new China plant aim to improve sales strategies and expand geographically, enhancing margins and growth potential.Article d’analyse • Apr 08
With A 31% Price Drop For Victrex plc (LON:VCT) You'll Still Get What You Pay For
Victrex plc ( LON:VCT ) shareholders that were waiting for something to happen have been dealt a blow with a 31% share...Article d’analyse • Mar 24
Victrex (LON:VCT) Is Finding It Tricky To Allocate Its Capital
When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...Article d’analyse • Feb 26
Are Investors Undervaluing Victrex plc (LON:VCT) By 49%?
Key Insights Victrex's estimated fair value is UK£18.18 based on 2 Stage Free Cash Flow to Equity Victrex's UK£9.32...Article d’analyse • Jan 15
Victrex (LON:VCT) Is Paying Out A Dividend Of £0.4614
Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 21st of February. Based on this payment, the dividend...Article d’analyse • Dec 06
Victrex plc (LON:VCT) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable
Victrex plc ( LON:VCT ) shareholders would be excited to see that the share price has had a great month, posting a 25...Article d’analyse • Sep 13
Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Article d’analyse • Aug 03
Shareholders Should Be Pleased With Victrex plc's (LON:VCT) Price
With a price-to-earnings (or "P/E") ratio of 29.8x Victrex plc ( LON:VCT ) may be sending very bearish signals at the...Article d’analyse • Jul 16
Does Victrex (LON:VCT) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Article d’analyse • Jun 14
There Are Reasons To Feel Uneasy About Victrex's (LON:VCT) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Article d’analyse • May 27
Calculating The Fair Value Of Victrex plc (LON:VCT)
Key Insights Victrex's estimated fair value is UK£14.70 based on 2 Stage Free Cash Flow to Equity With UK£12.96 share...Article d’analyse • Mar 16
Does Victrex (LON:VCT) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d’analyse • Feb 24
Returns On Capital At Victrex (LON:VCT) Paint A Concerning Picture
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...Article d’analyse • Jan 12
Victrex plc Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that Victrex plc ( LON:VCT ) filed its annual result this time last week. The early...Article d’analyse • Dec 08
Victrex (LON:VCT) Will Pay A Dividend Of £0.4614
Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.4614 per share on 23rd of February. This means...Article d’analyse • Nov 23
Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Article d’analyse • Oct 19
Is Victrex plc (LON:VCT) Trading At A 22% Discount?
Key Insights Victrex's estimated fair value is UK£17.25 based on 2 Stage Free Cash Flow to Equity Victrex's UK£13.47...PDG
James Routh (53 yo)
less than a year
Titularisation
Dr. James Mathew Routh, Ph D., is Chief Executive Officer & Executive Director of Victrex plc from January 1, 2026. Dr. Routh serves as Senior Independent Non-Executive Director of Tracsis plc since Septem...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Executive Director | less than a year | pas de données | 0.042% £ 351.3k | |
| Interim Chief Financial Officer | no data | pas de données | pas de données | |
| Group Human Resource Director | no data | pas de données | pas de données | |
| Managing Director for Medical | 3yrs | pas de données | pas de données | |
| Managing Director of Medical | less than a year | pas de données | pas de données | |
| Chief Commercial Officer | less than a year | pas de données | pas de données |
0.3yrs
Durée moyenne de l'emploi
Gestion expérimentée: L'équipe de direction de VCT n'est pas considérée comme expérimentée (ancienneté moyenne 0.3 ans), ce qui suggère une nouvelle équipe.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Executive Director | less than a year | pas de données | 0.042% £ 351.3k | |
| Independent Non-Executive Chair | 4.8yrs | UK£280.00k | 0.0080% £ 67.4k | |
| Non-Executive Director | less than a year | pas de données | pas de données | |
| Non-Executive Director | no data | pas de données | pas de données | |
| Independent Non-Executive Director | 8.6yrs | UK£68.00k | 0.0021% £ 17.7k | |
| Independent Non-Executive Director | 8.6yrs | UK£70.50k | 0.0036% £ 30.5k | |
| Senior Independent Director | 6.3yrs | UK£69.40k | 0.0022% £ 18.9k | |
| Independent Non-Executive Director | 2.3yrs | UK£58.50k | 0.00011% £ 928.1 |
3.5yrs
Durée moyenne de l'emploi
66.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de VCT sont considérés comme expérimentés (ancienneté moyenne 3.5 ans).
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/18 14:11 |
| Cours de l'action en fin de journée | 2026/09/18 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/09/30 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Victrex plc est couverte par 28 analystes. 11 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| James Stewart | Barclays |
| Katie Richards | Barclays |
| Gunther Zechmann | Barclays |